Bank of Montreal’s Sophiris Bio, Inc. SPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,171
Closed 5137
2019
Q4
$0 Hold
1,171
﹤0.01% 5166
2019
Q3
$1K Hold
1,171
﹤0.01% 4699
2019
Q2
$1K Hold
1,171
﹤0.01% 4825
2019
Q1
$1K Hold
1,171
﹤0.01% 4258
2018
Q4
$1K Hold
1,171
﹤0.01% 4638
2018
Q3
$3K Hold
1,171
﹤0.01% 4304
2018
Q2
$3K Sell
1,171
-10,039
-90% -$29.8K ﹤0.01% 4309
2018
Q1
$22K Hold
11,210
﹤0.01% 3539
2017
Q4
$25K Buy
11,210
+11,000
+5,238% +$23.9K ﹤0.01% 3523
2017
Q3
$0 Sell
210
-10,400
-98% -$21.6K ﹤0.01% 4491
2017
Q2
$23K Buy
+10,610
New +$26K ﹤0.01% 3499
2017
Q1
Sell
-4,310
Closed -$12K 4380
2016
Q4
$12K Buy
4,310
+3,620
+525% +$10.3K ﹤0.01% 3551
2016
Q3
$2K Sell
690
-942
-58% -$3.54K ﹤0.01% 3902
2016
Q2
$3K Sell
1,632
-48
-3% -$66 ﹤0.01% 3874
2016
Q1
$2K Sell
1,680
-1,952
-54% -$3.44K ﹤0.01% 4033
2015
Q4
$7K Buy
3,632
+2,000
+123% +$2.96K ﹤0.01% 3738
2015
Q3
$1K Hold
1,632
﹤0.01% 3953
2015
Q2
$1K Hold
1,632
﹤0.01% 3912
2015
Q1
$1K Hold
1,632
﹤0.01% 3943
2014
Q4
$1K Hold
1,632
﹤0.01% 3998
2014
Q3
$5K Hold
1,632
﹤0.01% 3817
2014
Q2
$3K Hold
1,632
﹤0.01% 4466
2014
Q1
$6K Hold
1,632
﹤0.01% 3793
2013
Q4
$6K Buy
1,632
+1,422
+677% +$6.02K ﹤0.01% 3530
2013
Q3
$1K Buy
+210
New +$968 ﹤0.01% 3764

Other funds holding SPHS

Bank of Montreal's SPHS Position: Q1 2020 in Review

Bank of Montreal sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 1,171 shares.

Bank of Montreal first reported a position in SPHS in Q3 2013 and held it in 25 quarters. The position peaked at $25K in Q4 2017. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

  • Bank of Montreal reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
  • Bank of Montreal sold 1,171 Sophiris Bio, Inc. shares in Q1 2020.
  • Bank of Montreal first reported a position in Sophiris Bio, Inc. in Q3 2013 and held it in 25 quarters.
  • Bank of Montreal's Sophiris Bio, Inc. position peaked at $25K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Bank of Montreal's 13F filing for Q1 2020, filed 13 May 2020.